Bethan Davies1, Katy M E Turner2, Maria Frølund3, Helen Ward4, Margaret T May5, Steen Rasmussen6, Thomas Benfield7, Henrik Westh8. 1. Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK. Electronic address: bethan.davies06@imperial.ac.uk. 2. School of Veterinary Science, University of Bristol, Langford, Bristol, UK. 3. Department of Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark. 4. Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK. 5. School of Social and Community Medicine, University of Bristol, Langford, Bristol, UK. 6. Department of Clinical Microbiology, Hvidovre University Hospital, Hvidovre, Denmark. 7. Department of Infectious Diseases, Hvidovre University Hospital, Hvidovre, Denmark; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. 8. Department of Clinical Microbiology, Hvidovre University Hospital, Hvidovre, Denmark; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Abstract
BACKGROUND: Uncertainty in the risk of reproductive complications (pelvic inflammatory disease, ectopic pregnancy, and tubal factor infertility) following chlamydia infection and repeat infection hampers the design of evidence-based chlamydia control programmes. We estimate the association between diagnosed chlamydia and episodes of hospital health care (inpatient, outpatient, and emergency department) for a reproductive complication. METHODS: We constructed and analysed a retrospective population-based cohort of women aged 15-44 years from administrative records in Denmark (1995-2012). We used a subset of the national Danish Chlamydia Study. The master dataset contains all residents of Denmark (including Greenland) who had a positive chlamydia test recorded by a public health microbiology laboratory from Jan 1, 1992, to Nov 2, 2011. Individuals were randomly matched (by age and sex) to four individuals drawn from the population register (Danish Civil Registration System) who did not have a positive chlamydia test during this interval. The outcomes in the study were hospital episodes of health-care (inpatient, outpatient, and emergency department) with a diagnosis of pelvic inflammatory disease, ectopic pregnancy, or tubal factor infertility. FINDINGS: The 516 720 women (103 344 positive, 182 879 negative, 230 497 never-tested) had a mean follow-up of 7·96 years. Compared with women with only negative tests, the risk of each complication was 30% higher in women with one or more positive tests (pelvic inflammatory disease, adjusted hazard ratio [AHR] 1·50 [95% CI 1·43-1·57]; ectopic pregnancy, AHR 1·31 [1·25-1·38]; tubal factor infertility, AHR 1·37 [1·24-1·52]) and 60% lower in women who were never-tested (pelvic inflammatory disease, AHR 0·33 [0·31-0·35]; ectopic pregnancy, AHR 0·42 [0·39-0·44]; tubal factor infertility AHR 0·29 [0·25-0·33]). A positive test had a minor absolute impact on health as the difference in the lifetime incidence of complications was small between women who tested positive and those who tested negative (pelvic inflammatory disease, 0·6%; ectopic pregnancy, 0·2%; tubal factor infertility, 0·1%). Repeat infections increased the risk of pelvic inflammatory disease by a further 20% (AHR 1·20, 95% CI 1·11-1·31). INTERPRETATION: A single diagnosed chlamydia infection increased the risk of all complications and a repeat diagnosed infection further increased the risk of pelvic inflammatory disease. Therefore, control programmes must prevent first and repeat infections to improve women's reproductive health. FUNDING: Unrestricted partial funding from Frederiksberg Kommune, Frederiksberg, Denmark. BD held an Medical Research Council Population Health Scientist Fellowship (G0902120). KT held an National Institute for Health Research Post-Doctoral Fellowship 2009-02-055.
BACKGROUND: Uncertainty in the risk of reproductive complications (pelvic inflammatory disease, ectopic pregnancy, and tubal factor infertility) following chlamydia infection and repeat infection hampers the design of evidence-based chlamydia control programmes. We estimate the association between diagnosed chlamydia and episodes of hospital health care (inpatient, outpatient, and emergency department) for a reproductive complication. METHODS: We constructed and analysed a retrospective population-based cohort of women aged 15-44 years from administrative records in Denmark (1995-2012). We used a subset of the national Danish Chlamydia Study. The master dataset contains all residents of Denmark (including Greenland) who had a positive chlamydia test recorded by a public health microbiology laboratory from Jan 1, 1992, to Nov 2, 2011. Individuals were randomly matched (by age and sex) to four individuals drawn from the population register (Danish Civil Registration System) who did not have a positive chlamydia test during this interval. The outcomes in the study were hospital episodes of health-care (inpatient, outpatient, and emergency department) with a diagnosis of pelvic inflammatory disease, ectopic pregnancy, or tubal factor infertility. FINDINGS: The 516 720 women (103 344 positive, 182 879 negative, 230 497 never-tested) had a mean follow-up of 7·96 years. Compared with women with only negative tests, the risk of each complication was 30% higher in women with one or more positive tests (pelvic inflammatory disease, adjusted hazard ratio [AHR] 1·50 [95% CI 1·43-1·57]; ectopic pregnancy, AHR 1·31 [1·25-1·38]; tubal factor infertility, AHR 1·37 [1·24-1·52]) and 60% lower in women who were never-tested (pelvic inflammatory disease, AHR 0·33 [0·31-0·35]; ectopic pregnancy, AHR 0·42 [0·39-0·44]; tubal factor infertility AHR 0·29 [0·25-0·33]). A positive test had a minor absolute impact on health as the difference in the lifetime incidence of complications was small between women who tested positive and those who tested negative (pelvic inflammatory disease, 0·6%; ectopic pregnancy, 0·2%; tubal factor infertility, 0·1%). Repeat infections increased the risk of pelvic inflammatory disease by a further 20% (AHR 1·20, 95% CI 1·11-1·31). INTERPRETATION: A single diagnosed chlamydia infection increased the risk of all complications and a repeat diagnosed infection further increased the risk of pelvic inflammatory disease. Therefore, control programmes must prevent first and repeat infections to improve women's reproductive health. FUNDING: Unrestricted partial funding from Frederiksberg Kommune, Frederiksberg, Denmark. BD held an Medical Research Council Population Health Scientist Fellowship (G0902120). KT held an National Institute for Health Research Post-Doctoral Fellowship 2009-02-055.
Authors: Laura C Chambers; Christine M Khosropour; David A Katz; Julia C Dombrowski; Lisa E Manhart; Matthew R Golden Journal: Clin Infect Dis Date: 2018-08-01 Impact factor: 9.079
Authors: Weiming Tang; Jessica Mao; Katherine T Li; Jennifer S Walker; Roger Chou; Rong Fu; Weiying Chen; Toni Darville; Jeffrey Klausner; Joseph D Tucker Journal: Sex Transm Infect Date: 2019-12-13 Impact factor: 3.519
Authors: B M Hoenderboom; A A M van Oeffelen; B H B van Benthem; J E A M van Bergen; N H T M Dukers-Muijrers; H M Götz; C J P A Hoebe; A A Hogewoning; F R M van der Klis; D van Baarle; J A Land; M A B van der Sande; M G van Veen; F de Vries; S A Morré; I V F van den Broek Journal: BMC Infect Dis Date: 2017-04-11 Impact factor: 3.090
Authors: Maartje Visser; Fleur van Aar; Femke D H Koedijk; Carolina J G Kampman; Janneke C M Heijne Journal: BMC Infect Dis Date: 2017-12-20 Impact factor: 3.090
Authors: Bethan Davies; Katy M E Turner; Thomas Benfield; Maria Frølund; Berit Andersen; Henrik Westh; Helen Ward Journal: PLoS Med Date: 2018-01-02 Impact factor: 11.069
Authors: Bethan Davies; Katy M E Turner; Stella Leung; B Nancy Yu; Maria Frølund; Thomas Benfield; James Blanchard; Henrik Westh; Helen Ward Journal: PLoS One Date: 2017-02-15 Impact factor: 3.240